ReviewFrontiers in pharmacology2025

PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise.

Jaya Rautela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.